Sentence examples for matched human prostate from inspiring English sources

We examined the expression level of miR-145 in 27 matched human prostate cancer laser microdissected tissue samples, and found a significant difference between adjacent normal and cancerous regions.

Intuitive pathway analysis was used for putative target discovery in 12 matched selections of human prostate SCs, transiently amplifying cells and terminally differentiated cells.

Here we report the characteristics of the predicted protein sequence of PSGR and its prostate tissue specificity and expression profile in human prostate cancer and matched normal tissues.

RNA-seq data from 3 human prostate adenocarcinoma and 3 matched adjacent normal samples was obtained from the SRA (SRP003611) [11].

EphB4 is expressed in prostate cancer cell lines with increased expression in human prostate cancers when compared with matched normal tissue.

EphB4 immunoreactivity in vivo was significantly greater in human prostate cancers as compared with matched normal prostate epithelium and there appeared to be a trend towards increased expression with higher grade disease.

The expression of miR-145 was low in all the prostate cell lines tested (PC3, LNCaP and DU145) compared with the normal cell line, PWR-1E, and in cancerous regions of human prostate tissue when compared with the matched adjacent normal.

Previously we identified strong expression of ALDH7A1 in human prostate cancer cell lines, primary tumors and matched bone metastases.

Nextbio analysis also revealed a highly significant match with a study comparing gene expression in human prostate cancer tissues.

We applied both methods to sets of single-end reads that we obtained by sequencing the transcriptomes of three primary human prostate adenocarcinomas (denoted by T1, T2, and T3) and their matched normal samples (N1, N2, and N3), as well as the human brain reference (HBR) and universal human reference (UHR) samples used in the Microarray Quality Control (MAQC) project [ 29, 30].

Each participant will be matched with collections of mouse proxies, with each group of mice engineered to carry different combinations of a few major human prostate cancer genes.